This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

National Research Corporation Published As Lead Story In April Issue Of Nursing Management. The Journal Of Excellence In Nursing Leadership.

LINCOLN, NEB., April 15, 2014 (GLOBE NEWSWIRE) -- National Research Corporation is excited to announce a recent article, "Creating a New Healthcare Landscape," published in the April edition of Nursing Management, a peer-reviewed journal that focuses on nursing leadership. The article is the lead story for the April 2014 print and online editions. In the article, Dr. Jennifer Volland discusses how the healthcare of tomorrow is considerably different than the healthcare of today, and it's imperative to focus on population health to achieve desirable outcomes. Understanding the legislative changes that impact a provider's care delivery and implementing patient-centered initiatives that influence the bottom line, Volland says, are keys to being successful in a time of significant healthcare reform. The article outlines how value-based services and population health initiatives are the new national priorities in today's evolving healthcare environment. Focusing on the hospital provider and patient interaction can be effective means of transforming healthcare at the frontline level—and help diminish the overall ripple effects that take place during evolving periods. "Keeping the human element intact as healthcare transforms to a population health focus will continue to remain among the essentials. The basics of wanting a human connection, someone that understands their personal needs, and a participatory advocate within the healthcare maze won't change," Volland said. Read the full manuscript to learn more. In addition, this article provides Continuing Education credits for nurses. Find out how to receive credits. Dr. Volland's role at National Research includes oversight of program development for the Patient Experience, Patient Outreach, Medical Group, and Payer programs and as faculty for The Governance Institute, a service of National Research. Prior to National Research, she worked in Administration as Vice President of Nursing at Cancer Treatment Centers of America and Assistant Vice President of Operations at Valley Baptist Medical Center. About National Research Corporation

For more than 30 years, National Research Corporation (NASDAQ: NRCIA and NRCIB) has been at the forefront of patient-centered care. Today, the company's focus on empowering customer-centric healthcare across the continuum extends patient-centered care to incorporate families, communities, employees, senior housing residents, and other stakeholders. Recognized by Modern Healthcare as the largest patient satisfaction firm in the U.S., National Research is dedicated to representing the true voice of patients and other healthcare stakeholders. This integration of cross-continuum metrics and analytics uncovers insights for effective performance improvement, quality measurement, care transitions, and many other factors that impact population health management. For more information, call 800-388-4264, write to info@nationalresearch.com, or visit www.nationalresearch.com .

CONTACT: Scott Smith
         Director of Marketing
         National Research Corporation
         800-388-4264
         scsmith@nationalresearch.com

National Research Corporation Logo

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs